Zhong Liang, Quan Xingpu, Dang Peizhu, Tang Manyun, Yu Hang, Guo Fengwei
Department of Cardiovascular Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Gastroenterology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Front Cardiovasc Med. 2022 Sep 27;9:933597. doi: 10.3389/fcvm.2022.933597. eCollection 2022.
Gastrointestinal bleeding (GIB) is one of the most serious complications of acute myocardial infarction (AMI) and is correlated with poor outcomes.
To evaluate the prevalence, risk factors and in-hospital mortality of GIB in patients with AMI.
This observational case-control study retrospectively enrolled consecutive patients with AMI from the Department of Cardiovascular Medicine and Cardiovascular Surgery of the First Affiliated Hospital of Xi'an Jiaotong University from January 2015 to December 2020. GIB after AMI was identified by International Classification of Diseases (ICD) codes from inpatient medical settings and validated by medical record review. AMI patients without GIB were accordingly classified as the control group. Propensity score matching (PSM) was used to match with the GIB group and the control group. All anonymized clinical data were provided by the Biobank of the First Affiliated Hospital of Xi'an Jiaotong University.
A total of 5,868 AMI patients were enrolled, 0.87% (51/5,868) of whom developed GIB after AMI. On the univariate analysis, history of diabetes, chronic kidney disease, Killip IV, a lower hemoglobin concentration, a higher serum level of creatinine, blood urea nitrogen and D-dimer were closely associated with the risk of GIB ( < 0.05). On the multivariable analysis, a lower hemoglobin concentration (OR: 0.93, 95% CI: 0.89-0.96, < 0.001) was independently associated with the risk of GIB. Patients with GIB had a much higher in-hospital mortality rate than those without GIB (14.3 vs. 2.1%, = 0.047). In-hospital mortality among patients with GIB after AMI appeared to be associated with a decreased hemoglobin concentration (OR: 0.93, 95% CI: 0.86-0.99, = 0.045) and Killip IV (OR: 51.59, 95% CI: 2.65-1,005.30, = 0.009).
The history of diabetes, poor renal function and heart failure were associated with the high risk of GIB in patients experiencing AMI. The in-hospital mortality in patients with AMI complicating GIB was higher than that in patients without GIB and was associated with a decreased hemoglobin concentration and high Killip classification.
胃肠道出血(GIB)是急性心肌梗死(AMI)最严重的并发症之一,且与不良预后相关。
评估AMI患者中GIB的患病率、危险因素及住院死亡率。
本观察性病例对照研究回顾性纳入了2015年1月至2020年12月期间西安交通大学第一附属医院心血管内科和心血管外科连续收治的AMI患者。通过住院医疗环境中的国际疾病分类(ICD)编码识别AMI后的GIB,并通过病历审查进行验证。将未发生GIB的AMI患者作为对照组。采用倾向评分匹配(PSM)方法对GIB组和对照组进行匹配。所有匿名临床数据由西安交通大学第一附属医院生物样本库提供。
共纳入5868例AMI患者,其中0.87%(51/5868)在AMI后发生GIB。单因素分析显示,糖尿病史、慢性肾脏病、Killip IV级、较低的血红蛋白浓度、较高的血清肌酐、血尿素氮和D-二聚体水平与GIB风险密切相关(P<0.05)。多因素分析显示,较低的血红蛋白浓度(OR:0.93,95%CI:0.89-0.96,P<0.001)与GIB风险独立相关。发生GIB的患者住院死亡率远高于未发生GIB的患者(14.3%对2.1%,P=0.047)。AMI后发生GIB的患者住院死亡率似乎与血红蛋白浓度降低(OR:0.93,95%CI:0.86-0.99,P=0.045)和Killip IV级(OR:51.59,95%CI:2.65-1005.30,P=0.009)有关。
糖尿病史、肾功能不全和心力衰竭与AMI患者发生GIB的高风险相关。AMI合并GIB患者的住院死亡率高于未合并GIB的患者,且与血红蛋白浓度降低和Killip分级较高有关。